Optipharm Obtains Patent for Alginate Microcapsules Used in Cell Encapsulation
[Asia Economy Reporter Kum Boryeong] Optipharm announced on the 17th that it has obtained a domestic patent related to 'Alginate Microcapsules for Cell Encapsulation and Its Manufacturing Method.'
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- The Era of 1.1 Million Foreign Workers: Ministry of Culture, Sports and Tourism and Hyundai Motor Group Introduce 'Safety Korean' to Manufacturing Sites
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Optipharm stated, "Using the microencapsulation manufacturing technology developed with epigallocatechin gallate (EGCG) dimers, we solved the problem of hydrogels easily degrading in vivo, not only improving cell viability but also enhancing the ability to protect internal cells from external physical stimuli," adding, "This can minimize immune responses."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
